Imperial Valley News Center
New Potential Cause for Alzheimer’s: Arginine Deprivation
- Details
- Written by Karl Bates
Durham, North Carolina - Increasingly, evidence supports the idea that the immune system, which protects our bodies from foreign invaders, plays a part in Alzheimer’s disease. But the exact role of immunity in the disease is still a mystery.
New technique could slash energy used to produce many plastics
- Details
- Written by Jim Scott
Boulder, Colorado - A new material developed at the University of Colorado Boulder could radically reduce the energy needed to produce a wide variety of plastic products, from grocery bags and cling wrap to replacement hips and bulletproof vests.
APA Urges End to Persecution of Women
- Details
- Written by IVN
Washington, DC - The American Psychological Association marked the one-year anniversary of the Boko Haram abductions of over 200 schoolgirls in Nigeria by calling on Congress to take action to ensure the basic rights of women and girls worldwide to live a life free of persecution and violence.
FDA approves first-of-its-kind corneal implant to improve near vision in certain patients
- Details
- Written by IVN
Washington, DC - The U.S. Food and Drug Administration approved the KAMRA inlay, a device implanted in the cornea of one eye (the clear, front surface) to improve near vision in certain patients with presbyopia. It is the first implantable device for correction of near vision in patients who have not had cataract surgery.
NIH awards new government-wide IT contract
- Details
- Written by IVN
Washington, DC - The National Institutes of Health Information Technology Acquisition and Assessment Center (NITAAC) announced the award of its newest government-wide acquisition contract (GWAC) for information technology: Chief Information Officers - Commodities and Solutions (CIO-CS). This new contract covers 10 years with potential funds totaling $20 billion to provide the entire federal government with IT solutions.
NIH launches largest clinical trial focused on HIV-related cardiovascular disease
- Details
- Written by IVN
Washington, DC - Researchers have begun enrolling participants in a multicenter international clinical trial to test whether statin administration can reduce the risk for major adverse cardiovascular events, such as heart attacks, strokes, and heart disease, in people with HIV infection. The trial is supported by the National Institutes of Health’s National Heart, Lung, and Blood Institute (NHLBI) and National Institute of Allergy and Infectious Diseases (NIAID).
Page 3310 of 3785